PB1944 EARLY CYTOTOXIC IMMUNE RESPONSE INCLUDING TUMOR SPECIFIC CYTOTOXIC T LYMPHOCYTES CAN BE OBTAINED IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH DASATINIB

Autor:	S. Hayashi, Y. Kaneko, H. Shioya, T. Jo, K. Horio, J. Taguchi, K. Noguchi
Rok vydání:	2019
Předmět:	Dasatinib Immune system business.industry Tumor specific Cancer research Medicine Cytotoxic T cell Hematology Chronic phase chronic myeloid leukemia business medicine.drug
Zdroj:	HemaSphere. 3:884
ISSN:	2572-9241
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e093c6b9a2bc68ba62e5727ec5dad763 https://doi.org/10.1097/01.hs9.0000566272.44891.61 Zobrazit plný text záznamu Plný text